So what's wrong with penicillin for strep throat?

Pediatrics

Volumn 113, Issue 6 I, 2004, Pages 1816-1819

  Shulman, Stanford T ^a   Gerber, Michael A ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEPHALOSPORIN; MACROLIDE; PENICILLIN V;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; HUMAN; MEDICAL RESEARCH; META ANALYSIS; METHODOLOGY; MINIMUM INHIBITORY CONCENTRATION; NOTE; PHARYNGITIS; PRIORITY JOURNAL; QUALITY CONTROL; RESPIRATORY TRACT INFECTION; SIDE EFFECT; STREPTOCOCCUS GROUP A; SYSTEMATIC REVIEW; TASTE; TREATMENT FAILURE;

ANTI-BACTERIAL AGENTS; CEPHALOSPORINS; CHILD; DRUG INDUSTRY; DRUG RESISTANCE; HUMANS; META-ANALYSIS; PENICILLINS; PHARYNGITIS; PUBLICATION BIAS; RESEARCH DESIGN; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; TONSILLITIS;

EID: 2542614528     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.113.6.1816     Document Type: Note

References (14)

1. American Academy of Pediatrics, Committee on Infectious Diseases. Red Book. 26th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2003:578-580
2. Dajani A, Taubert K, Ferrieri P, Peter G, Shulman S. Treatment of acute streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals, Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association. Pediatrics. 1995;96:758-764
3. World Health Organization. Rheumatic Fever and Rheumatic Heart Disease. Geneva, Switzerland: World Health Organization; 1988. Technical Report Series No. 764
4. Bisno AL, Gerber MA, Gwaltney JM Jr, Kaplan EL, Schwartz RH; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 2002;35:113-125
5. Levy SB. The Antibiotic Paradox: How the Misuse of Antibiotics Destroys Their Curative Power. 2nd ed. New York, NY: Perseus Publishing; 2001
6. Kaplan EL, Johnson DR, Del Rosario MC, Horn DL. Susceptibility of group A beta-hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997. Pediatr Infect Dis J. 1999;18:1069-1072
7. Casey JR, Pichichero ME. Meta-analysis of cephalosporin versus penicillin treatment of group A streptococcal tonsillopharyngitis in children. Pediatrics. 2004;113:866-882
8. Huque MF. Experiences with meta-analysis in NDA submissions. Proc Biopharm Am Stat Assoc. 1988;2:28-33
9. Ioannidis JP, Schmid CH, Lau J. Meta-analysis in hematology and oncology [review]. Hematol Oncol Clin North Am. 2000;14:973-991
10. Ioannidis JP, Lau J. Pooling research results: benefits and limitations of meta-analysis. Jt Comm J Qual Improv. 1999;25:462-469
11. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1-12
12. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial co-pathogenicity. Pediatr Infect Dis J. 1991;10:275-281
13. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J. 1994;13:1-7
14. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics. 1999;104:911-917